Source: Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Shane Hanon, Guy Brusselle, Maud Deschampheleire, Renaud Louis, Alain Michils, Rudi Peché, Charles Pilette, Peter Rummens, Daniel Schuermans, Hélène Simonis, Olivier Vandenplas, Florence Schleich. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry. Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020

Member's Comments

No comment yet.

Related content which might interest you: The German Severe Asthma Registry: Obesity is associated with asthma parameters Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 The Severe Asthma Registry – German data Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Gender and its relation to asthma phenotype and comorbidities in difficult-to-control asthma patients from Czech National Severe Asthma Registry Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Triple combination therapy in severe asthma: overview from the Italian Registry Severe Asthma (IRSA) Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry. Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Proportion of complete responders after one year of treatment with biologics for severe asthma - Results from the nationwide Danish Severe Asthma Register. Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Characteristics of severe asthmatics treated with omalizumab, mepolizumab or no biotherapy. Data from the Belgian Severe Asthma Registry (BSAR). Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Swiss Severe Asthma Registry (SSAR)- Good asthma control and high number of exacerbations. How does this fit? Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR) Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 Characterization of asthma exacerbations in outpatients – National survey Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Epidemiology and characteristics of severe asthma exacerbations in children Source: International Congress 2014 – Paediatric asthma: what is new for the clinician? Year: 2014 U-BIOPRED: Clinical characteristics of children with severe asthma (SA) and severe pre-school wheeze (SPSW) Source: International Congress 2014 – More paediatric asthma Year: 2014 Characteristics of the frequent exacerbator in U-BIOPRED adult severe asthma cohort Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Gender differences in patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR) Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies Source: International Congress 2014 – More paediatric asthma Year: 2014 The impact of obesity in patients with severe asthma in the Wessex Severe Asthma Cohort (WSAC) Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020